Andere talen uniQure N.V.

Aandelen

QURE

NL0010696654

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4,56 ^USD	-4,00%		-2,36%	-32,64%

12/04	Uniqure N.V. kondigt aan dat Paula Soteropoulos zich niet herkiesbaar stelt als niet-uitvoerend bestuurder	CI
02/04	UNIQURE N.V. : UBS herhaalt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Uniqure N.V. Announces Paula Soteropoulos Will Not Stand for Re-Election as Non-Executive Director	12/04
UniQure N.V.(NasdaqGS:QURE) dropped from S&P Biotechnology Select Industry Index	18/03
UniQure N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
UniQure Announces 2023 Financial Results and Highlights Recent Company Progress	28/02
UniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease	19/12
UniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease	19/12
UniQure N.V. Announces Update on Phase I/II Clinical Trials of Amt-130Gene Therapy for the Treatment of Huntington's Disease	19/12
UniQure N : December 2023 Huntington's Disease Program Update AMT-130	19/12
UniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	08/12
UniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	08/12
UniQure Says US FDA Clears Investigational New Drug Application for Fabry Disease Candidate	29/11
UniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease	29/11
UniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease	29/11
UniQure N.V. Announces FDA Clearance of Investigational New Drug Application for Amt-191 Gene Therapy for Fabry Disease	29/11
Worldwide Healthcare Trust net asset value slips in volatile markets	23/11
UniQure N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11
Earnings Flash (QURE) UNIQURE Posts Q3 Revenue $1.4M	07/11
UniQure: Q3 Earnings Snapshot	07/11
UniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress	07/11
UniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress	07/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen uniQure N.V.

Aandelen

QURE

NL0010696654

Andere talen

Filters